NDC 71872-7370
Omnipaque 300 mg per 1 mL injection, solution
On the label: Medical Purchasing Solutions, LLC.. It's repackaged: Medical Purchasing Solutions, LLC. rebottles it from GE Healthcare Inc.'s NDC 0407-1413.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| GE Healthcare (Shanghai) Co Ltd. | China (Shanghai) Pilot Free Trade Zone, China | Makes it | Problems found, fixed voluntarilyOct 30, 2025 · 6 inspections |
| GE Healthcare AS | Oslo, Norway | Makes it | Problems found, fixed voluntarilyApr 23, 2024 · 8 inspections |
| GE Healthcare AS avd Lindesnes | Lindesnes, Norway | Makes the active ingredient | Problems found, fixed voluntarilyFeb 7, 2025 · 2 inspections |
| GE Healthcare Ireland Limited | Carrigtohill, Ireland | Makes it | Problems found, fixed voluntarilyNov 5, 2021 · 4 inspections |
Repackaging site
- Medical Purchasing Solutions, LLC, Scottsdale, AZ, United States · repackages it
Recalls
- Mar 24, 2026 · Class II · GE Healthcare Ireland Limited
Presence of particulate matter
Lots: Lot# 17225029; Exp. September 3, 2028 Lot# 17265376; Exp. October 3, 2028 Lot# 17270885; Exp. September 10, 2028 Lot# 17292246; Exp. October 4, 2028 Lot# 17301805; Exp. October 18, 2028 Lot# 17301807; Exp. September 7, 2028 Lot# 17301810; Exp. October 20, 2028 Lot# 17304992; Exp. October 5, 2028 Lo… - Mar 24, 2026 · Class II · GE Healthcare Ireland Limited
Presence of particulate matter
Lots: Lot# 17333197; Exp. December 10, 2028 Lot# 17333198; Exp. November 17, 2028 Lot# 17396945; Exp. December 18, 2028 Lot# 17396948; Exp. December 22, 2028 Lot# 17396953; Exp. January 11, 2029 Lot# 17396956; Exp. January 9, 2029 Lot# 17423503; Exp. January 1, 2029 Lot# 17423525; Exp. January 3, 2029 Lo… - Oct 29, 2018 · Class II · GE Healthcare Inc. Life Sciences
Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.
Lots: Lot #: 14301544, Exp 21Sep21
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Iohexol: every company that makes it
- Form
- injection, solution, intra-articular; intrathecal; intravascular; intravenous; oral; rectal
- Strength
- 300 mg per 1 mL
- Approval
- NDA NDA018956
- On the market since
- Dec 26, 1985
- Package NDCs
71872-7370-1- Official label
- DailyMed (National Library of Medicine), updated Apr 28, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?